Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition.

Bayer

Agrar Wetter

Qlaira App

Farmaci e promemoria - Terapiù

Pest Expert 360° by Envu

Pillenalarm

Regenmeter App

Bayer Agrar Wetter Austria

Agrar Bestimmer AT

Bayer Advisor Program

Yaz Flex

Viewport Meta

IPhone / Mobile Compatible

Domain Not Resolving

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

Google Font API

Google Analytics

DNSSEC

Senior Vice President and Head of U.S. Communications for Bayer US, Communications Business Partner

Beth Roden

Engineering

Alex Borodin

Sales and Support

Alex Wen

Marketing and Product

Alexander Vounatsos

Amelia Sam

Finance and Administration

Amit Narkar

Amy Yang

Business Management

Andre Bahrami

Operations

Andre Menezes

Andre Zila

Paul Achleitner

Marijn Dekkers

Kemal Malik

Werner Wenning

Michael König

Helmut Panke

Melissa Saw

Jun Tang

Head of Brand Management

Juergen Eckhardt

Head at Bayer Venture Investments

Nuno Fontes

SVP, Head of Global Biologics Development

Heike Prinz

Head Of Commercial Operations EMEA, Member of the Pharmaceuticals Executive Committee

Kimberly Harrington

VP, Head of Digital Engineering

Daniel Paulson

Vice President Global Clinical Development

Tiffany McLaud

GM of Pain / Cardio / Skin Health / Consumer Health Accelerator

Andrew Chapple

Crop Science Division, representing SETAC DRAW

Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development.

Covercress is a biotechnology company that manufactures an oilseed crop for food, bioenergy, and cattle feed.

Aparito digitise clinical trials and capture real-world data through our eCOA platform using video assessments, wearable devices and ePROs

Pharmaceutical Public Companies With More Than 10 Employees

Investors Active in Needham, Massachusetts

Europe Companies With More Than 100 Employees (Top 10K)

Biotechnology Public Companies With More Than 100 Employees

Bayer is an enterprise with core competencies in the life science fields of healthcare and nutrition. They design their products and services to help people and the planet thrive by supporting efforts to address unprecedented challenges. Their businesses include pharmaceuticals, consumer health, and crop science. They focus on developing and commercializing products and solutions based on scientific knowledge.

Bill & Melinda Gates Foundation

Grant - Bayer

Temasek Holdings

Post-IPO Equity - Bayer

Leverkusen

Nordrhein-Westfalen

Germany

Europe

Cytokinetics and Bayer Announce Exclusive Licensing Collaboration for Aficamten in Japan

How biotech startups become unicorns

Bayer price target lowered by EUR 9 at JPMorgan

Bayer to Present New Prespecified Subgroup Analyses from Investigational Phase III FINEARTS-HF Trial in Patients with Heart Failure with LVEF ≥40% at AHA 2024

Bayer’s Receives FDA Clearance for MEDRAD® Centargo CT Injection System

Swiss Femtech Impli partners with Bayer for hormone monitoring

Bayer exercises option for Dewpoint’s dilated cardiomyopathy program

Bayer partners medtech firm Impli on fertility R&D

Bayer, Dewpoint to work on heart drug; Viking’s obesity manufacturing plans

Bayer's Pharmaceuticals division focuses on prescription products for cardiology, women's healthcare, oncology, hematology, and ophthalmology, including diagnostic imaging equipment and contrast agents.

Bayer's Crop Science division offers seeds, crop protection, and pest control solutions, aiming to enhance agricultural productivity and sustainability.

Bayer's Consumer Health division provides nonprescription products in categories like dermatology, nutritional supplements, analgesics, digestive health, and cold and flu remedies.

A treatment used in combination with ADT to reduce the risk of radiological progression or death in patients with metastatic hormone-sensitive prostate cancer.

An investigational compound for treating moderate to severe vasomotor symptoms associated with menopause.

A medication shown to reduce the risk of new-onset diabetes in patients with heart failure and a left ventricular ejection fraction of ≥40%.

United States

North America

India

Asia

Argentina

South America

Kenya

Africa

HTML5

Fonts.com

Google Maps API

Bootstrap

jQuery

Twilio

Facebook Comments

Akamai Intelligent Platform

Bayer owns Nebido

Bayer owns Leaps by Bayer

Bayer owns LANXESS

Bayer owns Bayer Pharmaceuticals

Bayer owns Bayer Open Innovation

Bayer owns Bayer HealthCare

Bayer owns Bayer Fine Chemicals

Bayer owns Bayer Diagnostics

Bayer owns Bayer CropScience

Bayer owns Bayer Biologics

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jul 14, 2024 5:03 PM	60d4c782
news daily refresh	general	Aug 20, 2024 11:40 AM	5e7273f5
news processing daily refresh	general	Aug 21, 2024 11:15 AM	cc6e5aa1
news impact assignment daily	general	Aug 21, 2024 11:43 AM	47062c9a
news processing basic	general	Jul 14, 2024 6:20 PM	75b67f77
company summary	general	Aug 21, 2024 1:51 PM	994f02b0
signals	general
crunchbase trigger	general	Nov 25, 2024 9:09 AM	f36c3188
crunchbase profile	general	Nov 25, 2024 11:09 AM	bbaec4b9
li profile	general
translate crunchbase fundingrounds	general	Nov 25, 2024 2:11 PM	5ec8b193
peers	general	Jul 14, 2024 5:03 PM	363b6e6a
news basic	general	Jul 14, 2024 5:03 PM	e837443e
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM

BR:COM:BANCOBV

Bayer